Back
Journey Medical Vs. Monopar Therapeutics Industry Stock Comparison
Buy
62
DERM
Journey Medical
Last Price:
$6.10
Seasonality Move:
24.77%
Sell
48
MNPR
Monopar Therapeutics
Last Price:
$41.84
Seasonality Move:
-14.17%
Buy
62
Journey Medical (DERM)
is a Buy
Is Journey Medical a Buy, Sell or Hold?
-
The current Journey Medical [DERM] share price is $6.11. The Score for DERM is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
DERM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $40.33. The Score for MNPR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DERM Stock Price Chart
What is Journey Medical's stock price today?
-
The Journey Medical share price today is $6.11Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DERM is experiencing buying pressure, which is a positive indicator for future bullish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $40.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.
DERM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.67 | Buy |
Relative Strength Index (14 RSI): | 60.9 | Buy |
Chaikin Money Flow: | 53879 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.1 - 5.94) | Buy |
Bollinger Bands (100): | (4.34 - 5.7) | Buy |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.01 | Buy |
Relative Strength Index (14 RSI): | 56.65 | Buy |
Chaikin Money Flow: | 2380 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.07 - 39.49) | Buy |
Bollinger Bands (100): | (19.65 - 39.65) | Buy |
DERM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.03 | Buy |
20-day SMA: | 5.55 | Buy |
50-day SMA: | 5.04 | Buy |
200-day SMA: | 5.19 | Buy |
8-day EMA: | 5.05 | Buy |
20-day EMA: | 3.07 | Buy |
50-day EMA: | 1.48 | Buy |
200-day EMA: | 0.41 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.86 | Buy |
20-day SMA: | 34.79 | Buy |
50-day SMA: | 37.86 | Buy |
200-day SMA: | 17.05 | Buy |
8-day EMA: | 38.75 | Buy |
20-day EMA: | 37.13 | Buy |
50-day EMA: | 35.15 | Buy |
200-day EMA: | 21.74 | Buy |
Journey Medical Earnings Growth & DERM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Journey Medical Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |